It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.
This guidance is produced to support the easy read FAQs on the same topic. It explores in more detail the ethical issues likely to be encountered during the COVID-19 outbreak and what good decision making requires.
This guidance is intended to support primary care staff during the COVID-19 Pandemic with requirements to work differently and making challenging decisions. It does not seek to replicate or replace national guidance. It seeks to answer frequently asked questions (FAQs) by members using an ethical prism. These FAQs will be updated as new guidance is added, events emerge, and new questions arise.
Ethical guidance concerning issues front-line staff will face while caring for patients during the pandemic. The Committee on Ethical Issues in Medicine reserves the right to change this advice at any time to reflect the current situation with the COVID-19 pandemic.
Guidance and recommendations produced by a short life working group convened by the Royal Pharmaceutical Society (RPS) to provide guidance to pharmacists and registered pharmacy technicians to assist with difficult decisions being made in the exceptional circumstances presented by COVID-19. It contains some guidance on structured decision making and some more specific examples relevant to the current pandemic.
Published in 2016, this document seeks to assist policy-makers, health care providers, researchers, and others prepare for outbreak situations by anticipating and preparing for the critical ethical issues likely to arise.